Evidence map›Paper›PMID 30400600›Full record

ReviewMolecules (Basel, Switzerland)2018

Anti-Obesity Effects of Medicinal and Edible Mushrooms.

Kumar Ganesan, Baojun Xu

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04081818 nacompletednot on this mapstarted 2021, after this paper: background citation

A Study on the Effects of Nutritious Mushrooms in Adults With Metabolic Syndrome

TypeinterventionalSponsorHarokopio UniversityRan2021 to 2022Enrolled100ConditionsMetabolic SyndromeArmsNutritious Mushrooms
NCT04444219 nacompletednot on this mapstarted 2020, after this paper: background citation

Postprandial Glucose, Insulin Responses and Appetite Hormones to Dried Mushrooms

TypeinterventionalSponsorHarokopio UniversityRan2020 to 2021Enrolled19ConditionsMetabolic SyndromeArmsBreakfast meals
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Frontiers in pharmacology · 2026
    Article
  5. Review
  6. Selenium-Enriched Submerged Fermentation ofFood science & nutrition · 2025
    Article
  7. Article
  8. Anti-Obesity Effects ofNutrients · 2024
    Article
  9. Modulatory Effects ofFoods (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. A Randomized Controlled Trial onAntioxidants (Basel, Switzerland) · 2022
    Article
  17. Nutrients · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Kumar GanesanFood Science and Technology Program, Beijing Normal University-Hong Kong Baptist University United International College, 2000, Jintong Road, Tangjiawan, Zhuhai 519087, China. kumarg@hku.hk.ORCID 0000-0002-3198-6066
Baojun XuFood Science and Technology Program, Beijing Normal University-Hong Kong Baptist University United International College, 2000, Jintong Road, Tangjiawan, Zhuhai 519087, China. baojunxu@uic.edu.hk.ORCID 0000-0003-0739-3735
Beijing Normal-Hong Kong Baptist University · CN

Funding

Beijing Normal University-Hong Kong Baptist University United International College R201714
6 · The paper itself

Abstract

Obesity is a group of metabolic disorders caused by multiple factors, including heredity, diet, lifestyle, societal determinants, environment, and infectious agents, which can all lead to the enhancement of storage body fat. Excess visceral fat mass in adipose tissue generate several metabolic disorders, including cardiovascular diseases with chronic inflammation based pathophysiology. The objective of the current review is to summarize the cellular mechanisms of obesity that attenuate by antioxidant potentials of medicinal and edible mushrooms. Studies have showed that mushrooms potentially have antioxidant capacities, which increase the antioxidant defense systems in cells. They boost anti-inflammatory actions and thereby protect against obesity-related hypertension and dyslipidemia. The practice of regular consumption of mushrooms is effective in the treatment of metabolic syndrome, including obesity, and thus could be a good candidate for use in future pharmaceutical or nutraceutical applications.

Indexed as

AgaricalesAnimalsAnti-Obesity AgentsBiological ProductsClinical Studies as TopicDisease Models, AnimalDrug Evaluation, PreclinicalHumansObesityTreatment OutcomeAnti-Obesity AgentsBiological Productsanti-inflammatoryanti-obesityantioxidantscholesterol-lowering effectsmedicinal and edible mushrooms

Identifiers

PMID30400600
PMCPMC6278646
OpenAlexW2899949506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.